Dietrich John Pauls

President and CEO at DiaMedica Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: DiaMedica Therapeutics Inc., 3 years.

DiaMedica Therapeutics Inc. Director · President & CEO
3 years · Since 2023

Chief executive roles

DiaMedica Therapeutics Inc. · President and CEO
Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 10, 2026 DiaMedica Therapeutics Inc. Grant or award +60,200 — —
Jun 23, 2023 DiaMedica Therapeutics Inc. Open-market purchase +12,787 $3.91 $49,997

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.